Carlo Traverso
Angel · Massachusetts
Board director at 3 startups that filed Form D raises since late 2024, mostly in Massachusetts.
- Stages
- Pre-seed, Growth
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- Dec 2023
Focus
Biotech & PharmaHealthcareRecent portfolio activity
Sources
- SEC Form D: Teal BioDec 27, 2023
- SEC Form D: Lyndra TherapeuticsJun 7, 2023
- SEC Form D: Bilayer TherapeuticsAug 4, 2023
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.